| Tretinoin | Approved Investigational Nutraceutical | FZD1 | 8321 |
upregulated | Tretinoin results in increased expression of FZD1 mRNA | 7q21.13 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD10 | 11211 |
upregulated | Tretinoin results in increased expression of FZD10 mRNA | 12q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD2 | 2535 |
downregulated | Tretinoin results in decreased expression of FZD2 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD3 | 7976 |
downregulated | Tretinoin results in decreased expression of FZD3 mRNA | 8p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD4 | 8322 |
downregulated | Tretinoin results in decreased expression of FZD4 mRNA | 11q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD4 | 8322 |
upregulated | Tretinoin results in increased expression of FZD4 mRNA | 11q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD5 | 7855 |
downregulated | Tretinoin results in decreased expression of FZD5 mRNA | 2q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD5 | 7855 |
upregulated | Tretinoin results in increased expression of FZD5 mRNA | 2q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD6 | 8323 |
upregulated | Tretinoin results in increased expression of FZD6 mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD7 | 8324 |
downregulated | Tretinoin results in decreased expression of FZD7 mRNA | 2q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | FZD7 | 8324 |
upregulated | Tretinoin results in increased expression of FZD7 mRNA | 2q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | G0S2 | 50486 |
upregulated | Tretinoin results in increased expression of G0S2 mRNA | 1q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | G2E3 | 55632 |
downregulated | Tretinoin results in decreased expression of G2E3 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | G3BP2 | 9908 |
upregulated | Tretinoin results in increased expression of G3BP2 mRNA | 4q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | G6PD | 2539 |
upregulated | Tretinoin metabolite results in increased expression of G6PD mRNA | Xq28 | |
| Tretinoin | Approved Investigational Nutraceutical | G6PD | 2539 |
upregulated | Tretinoin results in increased expression of G6PD mRNA | Xq28 | |
| Tretinoin | Approved Investigational Nutraceutical | GABARAPL1 | 23710 |
upregulated | Tretinoin results in increased expression of GABARAPL1 mRNA | 12p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GABARAPL2 | 11345 |
upregulated | Tretinoin results in increased expression of GABARAPL2 mRNA | 16q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GABARAPL3 | 23766 |
upregulated | Tretinoin results in increased expression of GABARAPL3 mRNA | 15q26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GABBR1 | 2550 |
downregulated | Tretinoin results in decreased expression of GABBR1 mRNA | 6p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GABBR2 | 9568 |
upregulated | Tretinoin results in increased expression of GABBR2 mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GABRB1 | 2560 |
upregulated | Tretinoin results in increased expression of GABRB1 mRNA | 4p12 | |
| Tretinoin | Approved Investigational Nutraceutical | GABRB2 | 2561 |
upregulated | Tretinoin results in increased expression of GABRB2 mRNA | 5q34 | |
| Tretinoin | Approved Investigational Nutraceutical | GABRB3 | 2562 |
downregulated | Tretinoin results in decreased expression of GABRB3 mRNA | 15q12 | |
| Tretinoin | Approved Investigational Nutraceutical | GABRP | 2568 |
downregulated | Tretinoin results in decreased expression of GABRP mRNA | 5q35.1 | |